| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
New England Research Institutes, Watertown, Massachusetts 02472
Address all correspondence and requests for reprints to: Dr. Thomas G. Travison, New England Research Institutes, 9 Galen Street, Watertown, Massachusetts 02472. E-mail: ttravison{at}neriscience.com.
Context: Although it is known that serum testosterone (T) concentrations decline with age, the relative contributions of changes in health and lifestyle to that decline have not been adequately assessed.
Objective: The objective of this study was to establish the relative importance of aging, health, and lifestyle in contributing to male T decline.
Design: A prospective cohort study of health and endocrine functioning in randomly selected men with a baseline visit (T1, 1987–1989) and two follow-up visits (T2, 1995–1997; T3, 2002–2004) was conducted.
Setting: An observational study of men residing in greater Boston, Massachusetts, was conducted.
Participants: Participants included 1667 men aged 40 to 70 at baseline; follow-up was conducted on 947 (57%) and 584 (35%) at T2 and T3, respectively.
Main Outcome Measures: Main outcome measures included total serum T, calculated free T (FT), and SHBG.
Results: There were substantial declines in total serum T and FT levels associated with aging alone. However, many health and lifestyle changes were associated with accelerated decline. A 4- to 5-kg/m2 increase in body mass index or loss of spouse was associated with declines in total serum T comparable to that associated with approximately 10 yr of aging. Results were similar for FT, but fewer factors were associated with SHBG after age was taken into account.
Conclusions: Both chronological aging and changes in health and lifestyle factors are associated with declines in serum T. Comorbidities and lifestyle influences may be as strongly associated with declining T levels as is aging itself over the short- to midterm. These results suggest the possibility that age-related hormone decline may be decelerated through the management of health and lifestyle factors.
This article has been cited by other articles:
 |
|
 |
|
  A. R. Kristal, J. M. Schenk, Y. Song, K. B. Arnold, M. L. Neuhouser, P. J. Goodman, D. W. Lin, F. Z. Stanczyk, and I. M. Thompson Serum Steroid and Sex Hormone-Binding Globulin Concentrations and the Risk of Incident Benign Prostatic Hyperplasia: Results From the Prostate Cancer Prevention Trial Am. J. Epidemiol., October 21, 2008; (2008) kwn272v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. A. Hall, G. R. Esche, A. B. Araujo, T. G. Travison, R. V. Clark, R. E. Williams, and J. B. McKinlay Correlates of Low Testosterone and Symptomatic Androgen Deficiency in a Population-Based Sample J. Clin. Endocrinol. Metab., October 1, 2008; 93(10): 3870 - 3877. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. J. Snyder Decreasing Testosterone with Increasing Age: More Factors, More Questions J. Clin. Endocrinol. Metab., July 1, 2008; 93(7): 2477 - 2478. [Full Text] [PDF]
|
|
|
|
|
|
F. C. W. Wu, A. Tajar, S. R. Pye, A. J. Silman, J. D. Finn, T. W. O'Neill, G. Bartfai, F. Casanueva, G. Forti, A. Giwercman, et al. Hypothalamic-Pituitary-Testicular Axis Disruptions in Older Men Are Differentially Linked to Age and Modifiable Risk Factors: The European Male Aging Study J. Clin. Endocrinol. Metab., July 1, 2008; 93(7): 2737 - 2745. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. A. Allan, B. J. G. Strauss, H. G. Burger, E. A. Forbes, and R. I. McLachlan Testosterone Therapy Prevents Gain in Visceral Adipose Tissue and Loss of Skeletal Muscle in Nonobese Aging Men J. Clin. Endocrinol. Metab., January 1, 2008; 93(1): 139 - 146. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
